These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 2799537

  • 1. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS, Nikolaeva AP, Bendikov EA, Blok IuE, Sukhareva GV.
    Sov Med; 1989; (7):79-81. PubMed ID: 2799537
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Use of "Essenciale" in the treatment of liver diseases].
    Pogromov AP, Ol'binskaia LI, Antonenko NI, Gitel' NP, Smolianitskiĭ AIa.
    Klin Med (Mosk); 1978 Oct; 56(10):97-101. PubMed ID: 362064
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS, Dzhalalov KD, Blok IuE, Bendikov EA, Ausheva LKh.
    Ter Arkh; 1986 Oct; 58(2):73-6. PubMed ID: 3704945
    [Abstract] [Full Text] [Related]

  • 5. [Hepason in the treatment of hepatocellular diseases].
    Stazka Z, Korolko A.
    Pol Tyg Lek; 1970 Jul 13; 25(28):1062-4. PubMed ID: 5451158
    [No Abstract] [Full Text] [Related]

  • 6. [Alphamercaptopropionylglycine in chronic hepatopathies].
    Cacciari G, Malaguti P, Zincati GC.
    Policlinico Med; 1972 Jul 13; 79(3):165-73. PubMed ID: 5051108
    [No Abstract] [Full Text] [Related]

  • 7. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI, Dudanova OP, Khavinson VKh.
    Sov Med; 1990 Jul 13; (6):85-8. PubMed ID: 2396134
    [No Abstract] [Full Text] [Related]

  • 8. [Use of ornithine carbamoyltransferase in the treatment of liver diseases].
    Caruso N, De Jacobis M, Roccato M, Sequino A, Sgoifo B, Tinello M.
    Clin Ter; 1984 Jul 15; 110(1):37-44. PubMed ID: 6237844
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of liver cirrhosis and chronic liver diseases with total liver extract].
    Borgo E.
    Minerva Med; 1965 Nov 03; 56(88):3735-9. PubMed ID: 5846626
    [No Abstract] [Full Text] [Related]

  • 10. [Trial of LL 650 in various hepatic diseases].
    Savoye B, Dietsch R, Chapuy M, Girard M.
    J Med Lyon; 1972 May 05; 53(228):675-6 passim. PubMed ID: 5084113
    [No Abstract] [Full Text] [Related]

  • 11. [Use of liver hydrolysates and corticosteroids in chronic hepatitis and liver cirrhosis].
    Bakulenko EF.
    Vrach Delo; 1976 Apr 05; (4):108-10. PubMed ID: 1007172
    [No Abstract] [Full Text] [Related]

  • 12. [Use of a titrated extract of Centella asiatica in chronic hepatic disorders (author's transl)].
    Darnis F, Orcel L, de Saint-Maur PP, Mamou P.
    Sem Hop; 1976 Apr 05; 55(37-38):1749-50. PubMed ID: 230597
    [Abstract] [Full Text] [Related]

  • 13. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A, Tsvetkova V, Krŭstev Z, Kostova N, Lukanov L.
    Vutr Boles; 1985 Apr 05; 24(5):39-43. PubMed ID: 4090451
    [No Abstract] [Full Text] [Related]

  • 14. [Lecithin-cholesterol-acyltransferase activity in chronic liver diseases].
    Gaskina TK, Dolgov AV, Kurilovich SA.
    Vopr Med Khim; 1987 Apr 05; 33(4):96-9. PubMed ID: 3660750
    [Abstract] [Full Text] [Related]

  • 15. [Preparations of alpha-lipoic acid: the dynamics of their content in the blood and their effect on hemostasis in lesions of the human liver].
    Loginov AS, Nilova TV, Bendikov EA, Petrakov AV.
    Farmakol Toksikol; 1990 Apr 05; 53(2):47-50. PubMed ID: 2115010
    [Abstract] [Full Text] [Related]

  • 16. [Clinical experience in the treatment of chronic liver diseases with Solcohepsyl extralysate].
    Arias Vallejo E.
    Folia Clin Int (Barc); 1966 Sep 05; 16(9):404-15. PubMed ID: 5990974
    [No Abstract] [Full Text] [Related]

  • 17. Studies on the effect of a liver hydrolysate on the hepatic circulation in chronic liver diseases.
    Obayashi A, Akioka H, Tazaki H.
    Arzneimittelforschung; 1972 Mar 05; 22(3):578-80. PubMed ID: 5067932
    [No Abstract] [Full Text] [Related]

  • 18. [On the problem of effects and side effects of steroids and liver hydrolysates in acute and chronic liver diseases].
    Kleine FD.
    Z Arztl Fortbild (Jena); 1966 Aug 01; 60(15):900-4. PubMed ID: 5995281
    [No Abstract] [Full Text] [Related]

  • 19. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ, Borg R.
    Minerva Dietol Gastroenterol; 1977 Aug 01; 23(3):237-42. PubMed ID: 372845
    [No Abstract] [Full Text] [Related]

  • 20. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
    Pfliegler G, Boda Z, Dalmi L, Weisz G, Misz M, Beck P.
    Ther Hung; 1984 Aug 01; 32(1):19-25. PubMed ID: 6571189
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.